Expression and clinicopathological significance of FSIP1 in breast cancerHao Zhang, Caigang Liu, Ming Sun et al.|Oncotarget|2015Cited by 24
Correction: Oct-4 and Nanog promote the epithelial-mesenchymal transition of breast cancer stem cells and are associated with poor prognosis in breast cancer patientsDan Wang, Caigang Liu, Ping Lü et al.|Oncotarget|2021Cited by 4